Daytime Sleepiness Archives

Jazz Pharmaceuticals completes U.S. divestiture of Sunosi to Axsome Therapeutics

Business, Daytime Sleepiness, Divestments, Narcolepsy, Obstructive Sleep Apnea (OSA), Sleep Disorders, Sleepiness, Therapeutics

Jazz Pharmaceuticals plc completed the divestiture of Sunosi (solriamfetol) in the United States. to Axsome Therapeutics Inc.

May 9, 2022/by PR Newswire

U.S. court denies Jazz Pharma bid to revive patents on narcolepsy drug

Cataplexy, Daytime Sleepiness, Generics, Narcolepsy, Neurological Disorders, Patent Invalidation, Shares, Sleepiness, U.S. Court Of Appeals, U.S. Patent and Trademark Office

A U.S. appeals court ruled invalid patents owned by Jazz Pharmaceuticals covering the company’ narcolepsy drug Xyrem, opening the door for Amneal Pharmaceuticals to launch a generic version of the medicine.

July 13, 2018/by Reuters Health